Trials / Conditions / Unresectable Stage III NSCLC
Unresectable Stage III NSCLC
3 registered clinical trials studyying Unresectable Stage III NSCLC.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Unknown | A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectab NCT04982549 | Shandong Cancer Hospital and Institute | Phase 2 |
| Terminated | Mobile Devices to Detect Early Pneumonitis in Stage III NSCLC Patients on Durvalumab. NCT04381494 | AstraZeneca | Phase 4 |
| Unknown | Endostar Combined With Concurrent Radiochemotherapy for Treatment of Unresectable Stage III NSCLC NCT04161352 | Zhejiang Cancer Hospital | — |